Published in

American Chemical Society, Journal of Medicinal Chemistry, 23(65), p. 15679-15697, 2022

DOI: 10.1021/acs.jmedchem.2c01041

Links

Tools

Export citation

Search in Google Scholar

Macrocyclization of Quinazoline-Based EGFR Inhibitors Leads to Exclusive Mutant Selectivity for EGFR L858R and Del19

Journal article published in 2022 by Jennifer A. Amrhein, Tyler S. Beyett ORCID, William W. Feng ORCID, Andreas Krämer, Janik Weckesser, Ilse K. Schaeffner, Jaimin K. Rana, Pasi A. Jänne, Michael J. Eck, Stefan Knapp ORCID, Thomas Hanke ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Upload
Orange circle
Postprint: archiving restricted
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO